It can be a labour of love to get a tablet to market. With time and monetary investments made throughout the process from research to development and scale-up, one of the most challenging steps in the process can be the actual manufacture of the product. Issues range from tablet quality to equipment malfunction – all of which can result in downtime and delayed market deployment. Kevin Queensen and Bill Turner at Natoli explain how tooling options can benefit different types of pharmaceutical formulations during tablet compression.